March 3, 2021
Preventing a serious cardiac event is a top priority for my patients, but the Institute for Clinical and Economic Review is about to make prevention a whole lot harder.
December 15, 2020
When you or someone you love has a cardiovascular event, life gets real – fast.
February 25, 2020
y Christopher Gottschalk, MD - What is the value of advanced medicine for a patient living with migraine? It’s not a simple question.
December 19, 2019
Before closing the door on 2019, IfPA looks back at the trends that impacted patient access this year.
December 3, 2019
The QALY gives a one-size-fits-all measure of value that doesn’t reflect the needs and experiences of real patients.
November 12, 2019
If you don’t know ICER, you should. IfPA’s new videos explain what the health economic organization is leaving out of…
October 22, 2019
Not only is cystic fibrosis a devastating disease, most patients living with cystic fibrosis do not have access to an…
September 10, 2019
ICER recently released an updated draft of its framework. What do these changes mean for real patients who want to access innovative medicine?
June 11, 2019
It’s that time again. The controversial Institute for Clinical and Economic Review is examining its value framework, the rules and assumptions it uses to analyze new drugs’ cost effectiveness.
June 7, 2019
Elated. Nervous. Hopeful. That’s how thousands of cystic fibrosis patients felt upon hearing last week’s news: the Food and Drug Administration will soon review a new triple combination therapy that could drastically improve their quality of life.
